Literature DB >> 20154347

Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.

Benedetto Ielpo1, Andres Sanchez Pernaute, Stefano Elia, Oreste Claudio Buonomo, Luis Diez Valladares, Elia Perez Aguirre, Giuseppe Petrella, Antonio Torres Garcia.   

Abstract

Lymph node involvement in adenocarcinoma of the esophagogastric junction (EGJ) is similar to that of gastric cancer. The impact on survival of the number and site of lymph nodes involved in a subgroup of patients undergone surgery for adenocarcinoma of EGJ is reported. Sixty-four patients undergone transthoracic esophagectomy with two-field lymphadenectomy for adenocarcinoma of the EGJ were retrospectively assessed. Five-year survival according to AJCC gastric cancer nodal classification and central node invasion was evaluated. In N0 patients survival was assessed in relation to the number of lymph nodes removed. Five-year survival was 72% in N0, 46% in N1 and 0% in N2 and N3 group. Intergroup differences were statistically significant (P<0.05) except between N2 and N3 groups. Overall survival was different depending on the infiltration of distal or proximal site nodes, 23% vs. 58% (P<0.05); in N0 patients it was related to the number of lymph nodes removed (83% >15 vs. 57% <15, P<0.05). Classification of lymph node involvement in adenocarcinoma of the EGJ by gastric cancer criteria is adequate for prognostic purposes. The involvement of distal nodes in all cases and the removal of <15 nodes in N0 group resulted as independent negative predictive factors. 2010 Published by European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20154347     DOI: 10.1510/icvts.2009.222778

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  7 in total

1.  Lymph node metastasis in gastric cardiac adenocarcinoma in male patients.

Authors:  Gang Ren; Ying-Wei Chen; Rong Cai; Wen-Jie Zhang; Xiang-Ru Wu; Ye-Ning Jin
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

2.  Background Parenchymal Enhancement in Contrast-enhanced Spectral Mammography: A Retrospective Analysis and a Pictorial Review of Clinical Cases.

Authors:  Rosaria Meucci; Chiara Adriana Pistolese; Tommaso Perretta; Gianluca Vanni; Emanuela Beninati; Federica DI Tosto; Maria Lina Serio; Aurelia Caliandro; Marco Materazzo; Marco Pellicciaro; Oreste Claudio Buonomo
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

3.  Acute Appendicitis During Coronavirus Disease 2019 (COVID-19): Increasing Incidence of Complicate Appendicitis, Severity and Length of Hospitalization.

Authors:  Marco Pellicciaro; Gianluca Vanni; Simona Grande; Marco Materazzo; Francesca Santori; Tatiana DI Cesare; Matteo Ciancio Manuelli; Daniele Sforza; Massimo Villa; Dario Venditti; Michele Grande
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

4.  A Prospective Evaluation of Tru-Cut Biopsy and Fine-needle Aspiration Cytology in Male Breast Cancer Detection.

Authors:  Chiara Adriana Pistolese; Tommaso Perretta; Giulia Claroni; Lucia Anemona; Francesca Servadei; Alberto Collura; Michela Censi; Marco Materazzo; Marco Pellicciaro; Feliciana Lamacchia; Gianluca Vanni
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

5.  Short-term postoperative complications and prognostic factors in patients with adenocarcinoma of the esophagogastric junction.

Authors:  Hui Zhang; WeiJian Zhang; DeFeng Peng; JinHai Zhu
Journal:  Thorac Cancer       Date:  2018-06-21       Impact factor: 3.500

Review 6.  Current surgical treatment of esophagogastric junction adenocarcinoma.

Authors:  Shun Zhang; Hajime Orita; Tetsu Fukunaga
Journal:  World J Gastrointest Oncol       Date:  2019-08-15

7.  Development and validation of a novel competing risk model for predicting survival of esophagogastric junction adenocarcinoma: a SEER population-based study and external validation.

Authors:  Tongbo Wang; Yan Wu; Hong Zhou; Chaorui Wu; Xiaojie Zhang; Yingtai Chen; Dongbing Zhao
Journal:  BMC Gastroenterol       Date:  2021-01-26       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.